Portal de Periódicos da CAPES

Hyperacute graft rejection during heart transplantation for giant cell myocarditis: A case report

2010; Elsevier BV; Volume: 206; Issue: 6 Linguagem: Inglês

10.1016/j.prp.2009.10.010

1618-0631

E Mutijima, Katty Delbecque, Jean-Olivier Defraigne, C Bouillenne, Pierre Damas, Luc Piérard, Jacques Boniver, Laurence de Leval,

SARS-CoV-2 and COVID-19 Research

We report the case of a patient with giant cell myocarditis who was bridged to transplantation with mechanical circulatory support and developed a fatal perioperative hyperacute rejection. The patient had received abundant transfusions that had raised her anti-HLA antibody titers. The cross-match test was positive. No pre-transplantation immunosuppressive therapy had been administered given concomitant infection. The severity and acuteness of the rejection in this case likely reflect the combined effect of preformed anti-HLA antibodies in the context of an active organ-specific immune process at the time of transplantation. This case raises the questions of the need for intensive immunosuppressive therapy before transplantation in giant cell myocarditis and of the management of patients with positive cross-match in the context of a giant cell myocarditis.